Informa PLC

Informa PLC

Informa is a leading business intelligence, academic publishing, knowledge and events business, operating within the Knowledge and Information Economy. We serve commercial, professional and academic communities in many different sectors by helping them connect and learn, and by creating and providing access to content and intelligence that helps people and businesses work smarter and make better decisions faster. We are organised into four Operating Divisions, with a fifth Division, Global Support, providing business services that support the Group and other Divisions. Informa has over 11,000 colleagues around the world.

Company details

5 Howick Place , London , SW1P 1WG United Kingdom


View in map

Find locations served, office locations, manufacturers and our distributors.

Business Type:
Publishing company
Industry Type:
Publishing / Media / Marketing
Market Focus:
Globally (various continents)
Year Founded:

Informa provides products and services based on content, intelligence and connections to specialist communities worldwide. 

These include academic books and journals, data-driven intelligence publications and services, exhibitions, conferences and learning platforms.

Learn more about each of our four Operating Divisions below, and the Group Strategy and Guiding Principles that underpin our approach.


To grow, do business, make breakthroughs and take better informed decisions, specialists need the support of other specialists.

Informa’s leading brands and expert teams operate events and exhibitions, deliver intelligence-based products and data-driven services, convene communities in person and digitally and provide access to cutting-edge research for specialist customer communities worldwide.

Each of our five operating divisions has a distinct focus. Learn more about the brands, products and services provided by our divisions below, and see our organisational structure and the guiding principles that underpin our business.

Informa is structured into five operating divisions, each working deeply in specialist customer markets: Informa Connect, Informa Intelligence, Informa Markets, Informa Tech and Taylor & Francis

Global Support is the team behind the teams, providing shared business services and expertise to each of the operating divisions.

Informa operates in a growing, global market for professional, commercial and academic knowledge and information.

Our aim is to generate sustainable value for shareholders and maintain positive, long-term relationships with customers, suppliers and our communities.

We do this by harnessing the ideas and contributions of our colleagues, our culture, brands, customer and partner relationships, financial capital and infrastructure to deliver products, services and outcomes that customers value.

This creates an overall Group portfolio with balance and breadth in revenue mix, geographies, verticals and products and services.

The 2014-2017 Growth Acceleration Plan

The Growth Acceleration Plan, or GAP, is how Informa focused on delivering the Group's aims between 2014 and 2017.

GAP is structured into six disciplines that represent the Group’s focus. In combination, they are intended to improve the overall operational fitness of the Group, strengthen core capabilities and build a platform for future sustainable growth.

Informa operates within the Knowledge & Information Economy, serving customers who work in highly specialist markets that are typically international, dynamic and have long term growth prospects.

Read on for examples of some of the specialist markets Informa works in, written by experts within the Group, and the trends that create opportunities for customers and demand for trusted, high quality information services products.


Endless opportunities

Artificial intelligence (AI) is entering a new growth phase, driven by the convergence of three trends: more data, faster hardware and better algorithms. Together, they are accelerating research, development and commercial investment in AI applications at lightning speeds. Many organisations are scaling from pilot deployments to full-scale, enterprise rollouts of AI technology within months, rather than years. Tractica forecasts that worldwide annual revenue generated from the direct and indirect application of AI software will increase from $5.4bn in 2017 to $105.8bn by 2025.

The breadth and velocity of the AI market have, however, led to increasing challenges for both technology adopters and suppliers, in maintaining the same pace of innovation with their products and integration plans. AI’s manifestation will shift alongside other technology macro trends: it is not the only show in town. Numerous other technologies, including the Internet of Things, augmented reality, virtual reality, blockchain, renewable energy, genomics and 3D printing will influence AI’s development, adoption and regulation.

Developing use cases

As the creation of data continues to increase exponentially and customers’ expectations of AI technology shift, companies must navigate the hype, adopt new capabilities and adapt their strategies, all while demonstrating improved efficiencies and generating new revenue streams.

Broadly, all AI falls into three macro categories: big data, vision and language. Although most people think of it as being driven by big data analytics, the larger growth opportunity is related to vision and language perception capabilities.

For end-users, AI interactions like robotics or autonomously moving machines are obvious, even tangible. But looking at other use cases, profound opportunities lie in forecasting, empirical decision making, operations automation, product optimisation, new business models, greater access to services, targeted services, enhanced user experiences and even improved environmental and public health. Simultaneously, AI poses many urgent challenges, from data privacy and re-skilling workforces to uncharted legal and regulatory questions.

Human interactions

AI currently has a complex relationship with humans that will change over time. While certain jobs will become automated, AI is more often poised to augment human labour and decision making. Longer term, many applications will be designed to empower humans with non-human capabilities, memory, experiences and knowledge. Various ethical, philosophical, cultural, societal and business norms will be forced into reassessment.
circuit board

The jury is still out regarding the ability of machines to seamlessly interact as a human would. While social media bots have effectively passed for Twitter and Facebook users, neither robots nor virtual digital assistants can disguise their code-based composition. Another area to consider is how companies are deploying AI to power virtual agents for consumer facing interactions. They must balance unprecedented opportunities for personalisation with significant risk of failure, faux pas or backlash.

Fragmented maturity

Maturity and the metrics for success in AI vary widely from application to application. Relatively low stakes applications, such as movie recommendations, are widely accepted and used, while others such as credit scoring or medical treatment recommendations remain regulatory grey areas and face significant barriers to widespread adoption. But AI applications mark the next evolutionary step in digital transformation. Computing, sensing, networking and data generation were only the beginning. The ability to process data more quickly and intelligently across systems, leveraging hardware, sensors and cameras, and to digitise language itself, marks the next era of enterprise transformation.


Clinical thinking

The Life Sciences industry enters 2019 with cautious optimism amid a great deal of change. Biotech innovation is booming, exit markets are robust, and new drug classes are emerging and gaining regulatory approval. At the same time, Western companies face increasing competition, the political and regulatory climate is mixed and the economics of healthcare remains a challenge.

Investment and consolidation

Innovation is moving fast, particularly in the US, where venture capital continues to pour into biotech companies in areas such as oncology, genomics and chronic diseases. In 2018, US Life Sciences firms reached a decade high in venture capital raised, while their European counterparts saw a smaller-scale increase.

Mergers and acquisitions surged in the past year, with 150-plus transactions worth a total of $148bn in disclosed deal values among therapeutics, diagnostics and medical device companies. The consolidation trend is hitting major players in pharmaceuticals and biotech. Bristol-Myers Squibb’s $74bn buy-out of Celgene, a merger of two oncology drug giants announced in early 2019, will impact research, development and drug pipelines worldwide.

Regulatory approvals

The drug industry continues to see an upswing in regulatory approvals, with the US Food and Drug Administration approving 59 new drugs in 2018, up from 46 the previous year. The European Medicines Agency approved 42 new active substances, up from 35 in 2017.

Meanwhile, regulatory changes in China have made it easier to develop drugs and get them approved for the fast-rising domestic market. China recently approved a drug developed by Western companies, an anaemia treatment from AstraZeneca and Fibrogen, before any other country.

Recent US drug approvals of note include the first-ever RNA interference drug; the first-ever cancer drug that targets a genetic fingerprint instead of a tumour’s location; and a new class of migraine medication. Conversely, despite breaking new ground, CAR-T immunotherapies for blood cancers have had mixed results commercially.

Progress in approvals should continue in 2019, with key clinical results expected to impact public health for years to come. After much hype and discussion around safety and ethics, the first clinical trials of CRISPR gene-editing therapeutics are slated to begin in the US. New drugs for neural disorders, such as depression and schizophrenia, are poised to receive regulatory approval, while novel approaches to Alzheimer’s and neurodegenerative diseases face crucial tests in patients.

Rising prices

Software and analytics are playing an increasing role in industry progress. Life Sciences companies continue to apply AI techniques, particularly in imaging, pathology and diagnostics.

Digital therapeutics have emerged, with regulatory approvals granted for new kinds of software to treat addiction and other disorders. Amazon, Microsoft and other tech giants are moving deeper into health, making advances in areas such as healthcare delivery and infrastructure.

The high cost of healthcare remains a difficult issue. Tension over rising drug prices is mounting, and biotech and pharma companies are preparing for new legislation. The US Government announced policy proposals to lower drug prices but the immediate future is unclear. Meanwhile, drug companies and insurers are signing more outcomesbased agreements, which tie the payment for a drug to its performance in patients. Drug makers have touted these approaches to control costs, but they might only be useful for a small group of drugs.

With some uncertainty in the regulatory environment, Life Sciences companies expect to save more of their cash in the short term, even as they navigate the substantial opportunities ahead.

Digital payoff

The global banking sector is in good health, with assets, profitability and capitalisation all having materially increased since the global financial crisis. Add the prospect of rising interest rates and relaxed regulatory pressures, and the retail banking industry appears in better shape than it has been for some time.

The landscape is changing, however. Technology, demographics, customer expectations and new competitors are forcing traditional retail banks, credit unions and mortgage lenders to change their business practices to avoid being left behind.

Forces of technology

Digital banking has transformed the way bank services are delivered and consumed. Bank of America announced in 2018 that, for the first time, deposits made through smartphones and tablets outpaced those made through branches.

And according to EY, 85% of banks say that implementing a digital transformation programme is a near-term business priority. The investment in technology to drive efficiency, manage evolving risks and capture growth opportunities will be critical for sustainable success.

The emergence of non-traditional disrupters means banks, credit unions, mortgage lenders and insurers have been forced to turn to big data, machine learning and advanced analytics to offer more directed product placement and capture new customers. Underpinning these goals and challenges is the need to make investment decisions based on real-time, granular data. The appetite for this type of intelligence varies depending on the size of the institution: larger institutions have developed sophisticated analytics while smaller ones require a synthesised view.

The traditional model of keeping all data in-house is being turned on its head. Peer contributed data exchanges are being formed across the financial services world and having access to this data will give retail banks important insights on price elasticity, market share, revenue enhancement, cost containment and more, helping them make better investment decisions faster. Open Banking in the EU, a regulation that allows the use of open application programming interfaces (APIs) to enable third party developers to build applications and services for banks, is a clear example of how this data and technology transformation is having a direct impact.

Demographics and customer expectations

Ensuring the best customer experience in the multi-channel world of brick and mortar branch, online and mobile banking is critical. The emergence of non-traditional banks is driving market opportunity as innovative, fast-moving lenders like Quicken, Freedom Mortgage, PennyMac and Nationstar have rapidly taken share from traditional mortgage banks. Quicken surpassed Wells Fargo as the single largest mortgage originator in the US, largely due to its customer experience.

Consumer loyalty to big bank brands has diminished and satisfaction with mobile and online functionality has decreased. Only 28% of US consumers say the experience they receive from their bank’s branch, online and mobile channels is seamless, according to Accenture.

New competitors

Consumers are willing and desirous to transact digitally, and nimble non-banks like Quicken have used technology to enhance the customer experience and reduce costs. Innovative fintech companies like Blend promise to make transactions faster and more consumer friendly, especially in the face of new regulations. These technologies offer the potential to jump ahead of incumbents with lower costs and superior customer experience.

The net result is that traditional models face significant margin pressure and must adapt or risk being left behind. And this is happening across lending, with companies like SoFi using these technologies to disrupt student lending, personal loans and other markets as well.

As consumers are forever wedded to their smartphones, the banking sector has changed forever. Matching attractive rates with the speed and execution of world-class, multi-channel customer experience are table stakes for retail banks worldwide.


Recipe for growth

The global pharmaceutical ingredient, processing and manufacturing market continues to mature, with the start of 2019 heralding significant acquisitions and major product announcements. Businesses in emerging markets like China and India are shaking up supply chains and bringing scrutiny from regulators and customers

Acquiring to stay ahead

Our CPhI Forecast predicts continued consolidation through mergers and acquisitions of startups. Larger companies will use their scale to bring these startups’ new technologies, biologics and drug delivery methods to market; recent notable acquisitions have focused on the development of cancer fighting drugs and the continued growth of biopharma and biotech.

These trends suggest that if large pharma companies want to keep filling their drug development pipelines, they will need to innovate through acquisition and continue to bring new technologies under larger research and development (R&D) budgets.

A question of trust

In order to meet the growing demands of ageing populations, global R&D investment is forecast to reach over $183bn by 2020. While R&D continues to be focused in Europe and the US, China and India are making large investments, including in large molecule biologics, and increasingly not only to support the global market but the domestic market as well.

The fastest-growing pharma countries realise the importance of increasing their reputation as reliable, reputable and transparent markets. According to the latest CPhI Report, published in October 2018, a survey of more than 2,000 industry professionals found that India and China were the countries whose reputations had increased the most in the previous 12 months.

Flattening supply chain

While the Pharma industry is facing scrutiny from regulators and the media, the pharma ingredients market is facing pressure for transparency, traceability and efficiency in production, pricing and delivery. However, with markets including China and India gaining industry trust and scale, the supply chain for active pharmaceutical ingredients is flattening.

As companies from emerging markets mature in this flattened supply chain, there is a growing expectation for them not only to meet the needs of the clients they are supplying but also to adhere to strict US Food and Drug Administration and European Medicines Agency regulations, to ensure they can reach consumers across the globe. The result is a growing need for pharma ingredients, contract services and packaging providers to develop strategies that work not only regionally but globally.
pill production line

With the supply chain becoming more closely controlled, integrated pharma supply companies have an opportunity to offer multiple services and solutions, from contract and lab services to sales. But everyone, from pharma companies to healthcare providers, needs to be able to trust the effectiveness of the process and of the end products.

Digital future

The drug delivery and packaging market is becoming highly competitive and is focusing on drug delivery innovations that meet efficiency standards and demand from digital healthcare systems.

The packaging community in particular has been investing in digital solutions, with innovations and research helping to bring new delivery methods to consumers, as well as new ways to track usage, dosage and efficiency. These digital offerings complement the overall trend of digitisation within healthcare, from patient records to drug usage, that will continue to offer opportunities for the pharma ingredients market.


Diversity and growth

While Asia is by no means a homogenous region, there are several business and economic trends common to a number of Asian markets, which make it an exciting place to do business and find commercial opportunities, particularly in exhibitions.

Countries such as China, India and Vietnam are growing at a much higher rate than the rest of the world as their economies develop and mature, with China’s GDP growth hitting 6.9% and India’s nearly 6.7% in 2017 according to the World Bank, compared with 3.1% globally.

Asia is also home to three of the five most populous countries in the world, creating large consumer markets for businesses to target. According to IATA’s 2018 data, Asia-Pacific recorded the largest year-on-year increase in international aviation traffic of any region, and India’s domestic market for air travel posted the highest annual growth rate of any country, with an 18.6% increase in demand.

When it comes to exhibitions, one of the great strengths of Asia is its appetite and level of national support for business, commerce and innovation.

In industries like Manufacturing, Automotive and Technology, Asia is increasingly taking a leading position in the global supply chain, and this creates huge demand from businesses to connect with national and international customers, something exhibition platforms provide at scale.

This alignment is reflected in the rapid expansion of the exhibitions industry in the region.

China became the world’s second largest exhibitions market in 2015 and was valued at $2.7bn in 2017, growing at 11%. Part of this growth is thanks to the construction of new venues in tier two cities as well as expansion of existing venues in the country’s largest hubs. In late 2019, the Shenzhen World Exhibition & Convention Center is slated to open, which will ultimately offer over 500,000 sq. m of exhibition space, the largest single exhibitions venue in the world.

This commitment to exhibitions as a source of international investment is a trend being mirrored in other countries across Asia.

For example, both Thailand and Indonesia have formed a national Convention and Exhibition Bureau, specifically to provide active support for the exhibitions market.

In a region as large and diverse as Asia, there is not a one-size-fits-all model for a successful exhibitions operating approach but there are common factors that are important. Local relationships are critical, as individual markets have their way of doing things, from dealing with local authorities and trade associations, to collaborating with partners and managing suppliers. Having a strong and recognised brand also helps, as trust and reputation are key.

Perhaps the most important factor is attracting talent. Exhibitions is by nature a people business, dependent on the commitment and focus of individuals to bring brands to life. With the growth and innovation happening around us in other industries, attracting high quality talent into the exhibitions industry is not easy. One of the ways we are addressing this is through local partnerships; for instance, we have collaborated with the South China University of Technology to create a training base for future event professionals.  In addition, our Asia operation is known for its internal training programmes which have proved successful in retaining and developing talent.

Our four guiding principles are a clear statement of what we believe in.

Taken together, they define our goals and provide a focus for all Informa’s activities. The principles give a perspective on our culture and way of working, making the company easier to understand, trust and do business with.


Think big. Act small.

We love ambitious thinking and taking bold options. At the same time, we recognise that success also comes from rolling up our sleeves, sweating the detail and taking personal ownership of the things that matter.


Trust must be earned.

We don’t just say we’re specialists, we live and breathe the subjects we work in and the communities we work with. By getting closer to our customers and partners, and offering support every step of the way, we build trust and the confidence to rely on us to do the right things, in the right way.


Success is a partnership.

We get to better answers by combining skills and talents, joining forces and embracing ideas, wherever they come from. This broadens perspectives, expands horizons, sparks innovation and keeps our thinking fresh.


More freedom. Fewer barriers.

We’re light on our feet. We do things swiftly, flexibly and with as few obstacles as possible. Our colleagues have the freedom and autonomy to think fast, act on opportunities and do what is best and most sustainable for us and our customers.


Informa Connect is a specialist in content-driven events and digital communities that allow professionals to meet, connect, learn and share knowledge.

We operate major branded events in Global Finance, Life Sciences and Pharma and in a number of other specialist markets, and connect communities online year-round.

About Informa Connect

Informa Connect organises major branded annual events and operates specialist digital communities that are key convening places for a particular market.

What we do

We run around 800 events each year in over 60 countries, create digital platforms based on engaging news and information content, and operate professional development programmes for individuals and businesses in Global Finance, Life Sciences and Pharma and in a number of other specialist markets.

Partnering with customers

Professionals in every specialist market have a need to meet, learn, network and be seen by peers and partners at their community’s most important events.

We create powerful and imaginative environments for businesses and professionals to connect and learn, and continually enhance our events with new features and innovative content and formats.

Our customers include delegates who pay to attend events and training. We also provide event-based and digital sponsorship and marketing opportunities for businesses looking to reach and connect with specialist communities.


Global Finance

Informa Connect's Global Finance business offers cutting-edge market-driven content and facilitated networking, delivered through major branded events and year-round digital platforms to specialist communities in international finance.

We are the leading event organiser for professional Finance communities, with specialist brands in the Private Equity, Investment Management, Banking and Payments and Fintech sectors. 

Informa Connect's Global Finance business operates over 200 events a year, which collectively attract more than 30,000 senior attendees and share the insight of over 6,000 leading speakers annually.  

Through our continually-enhanced live events, and our digital communities based on exclusive content, customers gain fresh insights, build relationships and create new commercial opportunities.


Life Sciences and Pharma

In the Life Sciences & Pharma market, Informa Connect helps customers acquire knowledge and develop relationships that drive new scientific discoveries and bring innovative life sciences products to market.

We run market-leading events such as BIO-Europe, BioProcess International and TIDES where thousands of executive-level attendees from industry and academia connect, learn, take investment decisions, advance their research and development plans and foster the networks necessary for success in the specialist Life Sciences industry.

Our Biotech events are supported by the powerful digital platform partneringONE, which enables matchmaking between those needing investment to develop new drugs and medicines and those looking to partner with innovative companies.

Informa Connect also operates digital communities that provide exclusive content and enable Life Sciences and Biotech companies to access potential partners year-round. We are proud to count many of the industry's major players among our customers, partners and supporters.


Specialist Conferences

Informa Connect operates specialist subject matter events, training and digital platforms for a range of markets that focus on exclusive content, engaging experiences and unrivalled networking opportunities. 

From hubs in Dubai, New York and London, we work with specialist communities in Maritime, Marketing, Energy, Law and the Catering industry amongst others.  

We are one of the world's leading events organisers for the Maritime industry, with major brands including CMA Shipping, North America's largest international shipping event. Informa Connect also operates the Lloyd's Maritime Academy, from which 1,000 professionals graduate each year. 

In the Insights, Marketing and Innovation community, our events enable over 5,000 people each year to meet, exchange ideas and enjoy curated experiences that support career growth and business development. 

Informa Intelligence

Informa Intelligence provides digital intelligence and data-based products, consultancy and research services that help businesses in specialist markets make better informed decisions, spot opportunities and gain competitive edge. 

We work in five markets, with over one hundred brands and many expert teams delivering predictive and action-based insight and intelligence. 

About Informa Intelligence

Informa Intelligence provides expert digital information and data products, consultancy and research services to over 25,000 businesses worldwide, helping companies operating in specialist markets make better informed decisions, spot opportunities and gain competitive edge.

What we do

We have over 100 brands, ranging from insight-focused products that provide market and trend analysis, to intelligence products that provide real time data and bespoke solutions including consultancy and direct access to experts.

Partnering with customers

In every specialist sector, businesses look for timely, relevant and high quality information and data to inform their commercial decisions, validate investments, identify new opportunities, win business and operate more effectively.

Our customers, who including leading international businesses in their sectors, subscribe to the intelligence, data and research services dedicated to their area of specialism, commission consultancy and bespoke research report, and purchase one off access to products. 

We continuously invest in our platforms and products, to maintain quality and deliver data and information in an ever more valuable way for customers.

Expert colleagues

Informa Intelligence has over 2,000 colleagues working worldwide, many of whom are deeply expert in their specialist market and apply critical thinking and expertise for the benefit of customers. Our teams include analysts and researchers, journalists and editors, data scientists, product developers and more.


Pharma Intelligence

Relying on us to deliver vital advantage when making critical R&D and commercial decisions, our customers come from over 3000 of the world’s leading pharmaceutical, contract research organisations (CROs), medical technology, biotechnology and healthcare service providers, including the top 10 global pharma and CROs.

From drug and device discovery and development to regulatory approval, and from product launch to lifecycle management, we provide the intelligence and insight to help our customers seize opportunities, mitigate risk and make business-critical decisions, faster.

As the pharma and healthcare sector faces unparalleled upheaval, customers rely on our independent advice, enabling them to cut through the clutter and make sense of changing drug development, regulatory and competitive landscapes.

From early phase and portfolio decisions to clinical research and development and commercial planning and analysis, our services include a suite of complementary subscription news, data and analysis services, expert analyst reports and consulting capabilities from the world’s leading pharma and healthcare R&D and informa intelligence brands – Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack, Biomedtracker, Scrip, Pink Sheet, In Vivo.


Financial Intelligence

We help customers around the world make well informed investment decisions, understand past trends, forecast future performance, drive profitability, and increase returns.

Our leading-edge financial information enables customers to gain a competitive advantage by using our research to make timely business-critical decisions and form effective strategies. 
We are a premier data provider for a diverse range of consumer and investment companies globally, serving the following markets:

  • Retail Banking
  • Investment & Asset Management
  • Wealth Management


Transportation Intelligence

Transportation Intelligence is the business-information hub for the global trade, maritime, legal, insurance, automotive, commercial vehicles and fleet.

Our customers rely on the critical advantage our intelligence delivers, from on-the-ground reporters and live market-leading data to help mitigate and minimise risk during times of crisis, to discovering new business opportunities.

Helping our customers reach new heights

We deliver vital industry information to millions of manufacturers, suppliers, militaries, and governments as well as professional observers, and we maintain a strong reputation in niche verticals. In trucking we provide critical business-information to nearly 1.5 million professionals who design, build, buy, sell, operate and support cars, light vehicles, trucks and trailers worldwide.

Your eyes and ears on the ground

FleetSeek lists 400,000 North American trucking operations and contacts used for sales leads by thousands of progressive industry suppliers and participants.

Information is Power in shipping

We enable customers to gain competitive advantage and minimise risk with best-in-market vessel tracking, ship characteristics, casualty and ownership intelligence through Lloyd's List Intelligence.  

Lloyd’s List has remained the most trusted source of news, analysis and insight in global shipping since 1734. We provide accurate in-depth insights and market knowledge that help users anticipate market shifts, avoid risks, spot opportunities and make better business decisions.

Additionally, through Lloyd's List Intelligence Consulting, we offer an unrivalled fleet and shipbuilding forecasting and strategic planning service to give you guidance on market positioning and competitive advantage, help you understand how seaborne trade and traffic trends, whether international, regional or country-specific, will affect your business.

Cutting-edge access to legal research

Providing specialist legal research, Lloyd’s Law Reports and i-law enable our customers to carry out legal research in minutes rather than hours. We offer a timely cutting-edge solution in a format that suits each user: combining case reports, analysis and news from industry-leading publications. 

Covering the most comprehensive range of insurance markets

Insurance Day covers the maritime insurance and reinsurance markets, with news and market intelligence delivered from an industry perspective, taking into consideration the inter-related

trends and issues that influence our customers’ businesses. Our news, analysis and intelligence service is available on multiple platforms to keep users informed whenever and wherever they work and to help them to make better decisions, faster.


Infrastructure Intelligence

Infrastructure Intelligence provides essential information, insight and intelligence on trends and technologies in utilities, power, buildings electronics, and design & manufacturing.

Infrastructure Intelligence’s brands reach millions of decision makers in the businesses that keep economies moving.

Our deep expertise in these markets and reach amongst businesses also means we can offer innovative, impactful and data-driven marketing solutions to those looking to reach decision makers at each stage of their purchasing journey.


Informa Markets creates platforms for international markets to trade, innovate and grow. 

Through over 500 leading brands, our exhibitions, specialist digital content and data solutions allow customers operating in specialist markets to meet and trade, and for their businesses and markets to thrive.


Our events

Informa Markets produces more than 500 international B2B events and brands each year.

Our events and brands bring a diverse range of industries and specialist markets to life, as they have significant international reach and industry depth and breadth. They create platforms for customers, partners and communities to engage, trade and grow, helping them thrive 365 days a year.


Informa Tech is a specialist in technology.

We aim to inspire the global technology community to design, build and run a better digital world through research, media, training and events that inform, educate and connect businesses and professionals working in technology.

About Informa Tech

Informa Tech provides specialist research, media, events and training to businesses and professionals working in technology.

The division houses all of Informa's brands and businesses that deliver services to specialist technology communities worldwide.

What we do

We aim to inspire the global technology community to design, build and run a better digital world, by providing research, media, events and training that inform, educate and connect businesses and professionals working in technology.

Our brands include major annual events and event series such as 5G World, Black Hat, AfricaCom, London Tech Week, GDC and AI Summit, research and intelligence services from Ovum, Tractica and Heavy Reading, and media such as Wards Auto, Information Week, Light Reading and

Partnering with Customers 

Informa Tech operates in a number of specialist Technology subject matter areas and communities, including the markets for communications technology, enterprise IT, artificial intelligence, networks, the internet of things, cybersecurity, big data and the connected economy. 

Our customers include the 7,000 subscribers to our research, nearly 250,000 attendees to our events each year, the four million people that read our digital content each month and over 18,000 students to our training programmes. 

Expert Colleagues

Informa Tech has around 600 colleagues working worldwide, from hubs in London, San Francisco, New York amongst other cities.


Critical Communications

Informa Tech provides a range of media and events in the specialist market of Critical Communications: where public safety and technology meet.

Public safety organisations are increasingly transitioning towards digital and LTE networks, and exploring investments in drones, wearables and surveillance technology to meet citizen expectations and emerging threats as well as to address budgetary constraints.

Informa Tech's media brands, which include IWCE's Urgent Communications, Government Procurement and American City & County, help public safety citizens stay up to date with the latest trends while our events, which include Mission Critical Technologies, help customers connect and learn.


Emerging Technologies

Emerging technology is the name given to the newest technology with the most exciting potential to create change and progress in multiple markets and industries.

To help inspire the global technology community to design, build and run a better digital world, our intelligence, research, events and education span the newest emerging technologies, from the Internet of Things and Connected Devices to Artificial Intelligence, Robotics, Automotive Technology and support for start ups looking to create the next big digital disruption.

Informa Tech's leading brands include AI Summit, the world's largest AI event series for business, research and intelligence-focused Tractica, TU-Automotive and North America's largest Internet of Things event, IoT World.


Enterprise IT

For businesses in every sector, all around the world, the ability to harness technology and deploy digital ways of working in operations and processes is paramount. 

In the fast-moving world of Enterprise IT, Informa Tech serves customers operating in a number of specialist subject areas from cloud and data centre management to enterprise communications, contact centres and service management. 

We aim to inspire, inform and educate business and technology leaders working in Enterprise IT, through media including InformationWeek, event brands such as Channel Partners and Cloud & DevOps World, the Telecoms & Tech Academy and our Ovum research and consulting capabilities, helping customers solve business problems and add value through new technologies.


Marketing Technologies

The Content Marketing Institute, part of Informa Tech, serves professional business-to-business marketers looking to advance their content marketing through the application of technology and digital strategies. 

We aim to advance the practice of content marketing by providing expert insight through our media platforms, webinars, training and industry research, plus learning and connection opportunities through face-to-face events. 

Over 200,000 readers a month get their news and insight from our content, and over 6,000 professionals learn tips and techniques for raising brand awareness and deploying the latest technologies from the Content Marketing Institute University.


Media and Entertainment

With the global rise of streaming and any-place any-time video consumption, the leading media and entertainment businesses are adapting to change and looking to capitalise on new business models and distribution methods.

Informa Tech aims to keep professionals in this specialist market in-the-know about all aspects of the business of video content creation and distribution, and the technologies that underpin the industry.

We provide daily news and analysis to 850,000 readers a month through the Digital TV Europe, Television Business International and Gamasutra platforms, and provide information and networking opportunities to 35,000 attends to events including GDC and the Video Exchange Series events.



Companies around the world are making an unprecedented investment in their online defences to address growing digital threats and cybercrime.

Informa Tech's media, events, training and research help businesses and professionals stay on top of the latest developments in information security trends and strategies, make better informed investment decisions when it comes to defence solutions, and train and educate security professionals at all career levels in the latest systems and techniques.

Over 250,000 professionals read our security content each month, including on the Dark Reading community, while nearly 25,000 people attend our Black Hat cybersecurity events and 4,500 professionals and students attend our training programmes.


Service Provider

Informa Tech provides media, events, training and research to customers in the specialist network service provider market.

The competitive landscape for service providers is more intense than ever, due to the demands of customers and the arrival of agile, cloud-native service providers.

Technology is also in state of transition thanks to the move from hardware-based systems to virtual, software-centric implementations and the arrival of 5G and AI.

For service providers looking to make better informed decisions when it comes to infrastructure investment and development, develop new services and find their next business opportunities, we offer trusted information and curated connections through the digital communiites Light Reading and, events including 5G Series and ConnecTechAsia, our Telecoms & Tech Academy and research specialist Ovum.


Taylor & Francis is specialist in scholarly research and in helping academic and research communities make new breakthroughs.

We commission, curate, produce and publish scholarly research and reference-led content in specialist subject areas, helping to advance research and enabling knowledge to be discovered and shared.

About Taylor & Francis

Taylor & Francis, a division of Informa, is a specialist in scholarly research and in helping academic and research communities make new breakthroughs.

We work with researchers, authors, editors, reviewers and customers across the international academic community, publishing 145,000 book titles and 2,700 journals under highly-regarded imprints including Routledge, CRC Press, Taylor & Francis, Cogent OA and Dove Medical Press.

Taylor & Francis content spans many specialist subject categories. We have a particular strength in Humanities & Social Sciences research publishing, including areas such as Archaeology, Psychology and Education, and in the Biomedical, Life Sciences, Physical Sciences and Engineering fields.

What we do

Taylor & Francis commissions, curates, produces and publishes scholarly research and reference-led content, enabling the latest academic thinking and discovery to be shared and built on.

Our expert editorial teams oversee the submission and acceptance process for research content, whether in book or journal format, and we co-ordinate independent peer review processes to ensure that published content is of the highest quality and reflects new thinking and cutting-edge discovery.

We operate the production process for research content, whether the final product is in digital or physical format, and continuously invest in technology and platforms that make research available, accessible and searchable now and for generations to come.

Our teams also work closely with researchers and authors, promoting their work and maintaining the quality and strength of our imprints and brands.

Digital and discoverable

We continually invest in technology that makes current and historical content discoverable and usable, creating a great reader experience and ensuring knowledge from centuries ago can be readily searched and accessed today.

All our journals are published digitally. Over 85% of our books content is available in a digital format and books can be purchased in print or e-book format, and searched at a book, chapter and paragraph level.

An international business  

Taylor & Francis has 2,000 colleagues around the world, with hubs in the US (Philadelphia, Boca Raton), UK (Oxford) and India (New Delhi) and teams in New Zealand, Australia, Singapore, Japan, Malaysia and Stockholm. 



Taylor & Francis publishes over 7,000 new books each year and maintain a books backlist of around 145,000 titles, with a particular specialism in Humanities and Social Sciences content.

Taylor & Francis is continuously digitising content and investing in technology to make scholarly thinking and research in book format searchable and usable, to maximise how easily it can be found and used by readers and researchers today.

Around 85% of all our books titles are available digitally, and all recently published or front list titles. Around 25% of our book sales each year are in eBook format.



Taylor & Francis publishes 2,700 high quality, peer reviewed journals under imprints including Dove Medical Press, Cogent OA, Routledge and Taylor & Francis.

All our journals are published digitally, with articles downloaded 150m times from Taylor & Francis Online in 2018.

Supporting researchers and academics

Taylor & Francis provides support to specialist academic community, including expert resources for editors, authors and reviewers, from video guides and knowledge centres to dedicated events.

Access Author Services and Editor Services hubs, and watch the video below to find out what is involved in being a journal editor.

Open Access and flexibility in publishing

Taylor & Francis offers a wide range of high-quality peer-reviewed journals in which authors can choose to publish through an open access model.

We have over 300 pure Open Access journals including those by Dove Medical Press and Cogent OA, as well as more than 2,000 journal titles that offer open access options under the Taylor & Francis and Routledge imprints.


Publishing Partnerships

Taylor & Francis is committed to open communication and active engagement with the communities and stakeholders we serve.

Authors & Editors

Authors and editors are the lifeblood of Taylor & Francis, so we provide the best publishing service and experience for them. Our authors are given access to a global distribution network, high-quality production services for print and digital products, and customised marketing campaigns that reach diverse audiences quickly and effectively.

Stanley Manahan,

University of Missouri, Columbia, USA


Taylor & Francis meets the needs of the library community; we believe there is much to be gained by working together to navigate the ever-changing landscape of scholarly communication in all its forms. Read our most recent white paper Use of social media by the library - Current practices and future opportunities, which covers the use of social media in libraries.


Taylor & Francis has partnerships with over 470 learned societies and professional associations worldwide. Partnership with us brings economies of scale, cutting-edge publishing technology, world-class marketing and global sales reach.  We also take care to preserve the attention to detail and personal touch that the research community associates with your journal.

Global Support is Informa's sixth division, with hubs in the United Kingdom, United States and Singapore.

As the team behind the teams, Global Support colleagues provide shared, efficient business services and function-specific expertise to each of Informa's operating divisions, enabling our commercial teams to focus on their markets and customers.

  • Corporate Development

    Maps business goals, develops Group-wide strategy and identiifies business development opportunities and potential acquisitions.

  • Group Finance, Tax and Treasury

    Responsible for raising finance to fund Informa’s growth and operations, co-ordinating the information used by management, and overseeing finance functions across the Group.

  • Intellectual Property

    Protects, manages and delivers value from some of Informa’s key intellectual property assets such as brands.

  • Investor Relations, Brand, Corporate Communications and Sustainability

    Manages Informa’s profile, reputation, engagement and relationships with internal and external audiences, and leads the Group’s sustainability activities.

  • Legal and Company Secretary

    Central team of experts in commercial, risk and compliance matters, who ensures the company meets legal and regulatory obligations and acts with integrity.

  • Shared Service Centres

    Our European, Americas and Asia Shared Services Centres oversee common finance and HR tasks that enable Informa’s Operating Divisions to work efficiently.